Lilly's $1/Day Pill, Cracking Iran Ceasefire, and Tesla's Last Hope

GLP-1 meets Amazon. Oil back near $100. Tesla needs this new SUV to work. ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  

April 10, 2026 Why Eli Lilly’s GLP-1 Pill Could Give the Pharma Giant the Entire Market Eli Lilly is partnering with Amazon to offer Foundayo at $1/day insured or $5 cash-pay, potentially turbocharging GLP-1 access and sales. With LLY’s GLP-1 sales surging as Novo Nordisk declines, LLY is positioned for market dominance. Read more. › Sponsored SpaceX Is Going Public What every investor must know before June 2026. READ FREE REPORT NOW › Iran Truce Cracks in Hours: Here’s the Play Whether Oil Hits $100 or Tumbles Again The Iran ceasefire is already cracking with oil rebounding near $100 after a 17% plunge. Energy stocks provide investors exposure that benefits from either rising production profits or cheaper refining feedstock amid uncertainty. Read more. › Can Tesla Avoid a Three-Peat? A New Smaller, Cheaper SUV Could End the Delivery Drought Tesla faces its first back-to-back-to-back annual sales declines. The EV maker is ready to build a new compact SUV as a potential fix, but TSLA’s high valuation and execution risks mean investors should proceed cautiously. Read more. › You are receiving this e-mail at lestyantoro14@gmail.com, as part of your subscription to Money Morning. Manage Your Preferences by clicking here. No longer interested? Unsubscribe. © 2026 Money Morning. All Rights Reserved. Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before our subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after on-line publication prior to following an initial recommendation. Protected by copyright laws of the United States and international treaties. This Newsletter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of: Agora Media, 14 West Mt Vernon Place, Baltimore, MD 21201. Money Morning is a First Light Financial, LLC publication. To contact us call 866-616-2166 or visit us online. Website  |  Privacy Policy  |  Terms & Conditions